DiaMedica Therapeutics Inc. (DMAC)
NASDAQ: DMAC · Real-Time Price · USD
3.505
-0.035 (-0.99%)
Apr 21, 2025, 4:00 PM EDT - Market closed
DiaMedica Therapeutics Employees
As of December 31, 2024, DiaMedica Therapeutics had 28 total employees, including 27 full-time and 1 part-time employees. The number of employees increased by 9 or 47.37% compared to the previous year.
Employees
28
Change (1Y)
9
Growth (1Y)
47.37%
Revenue / Employee
n/a
Profits / Employee
-$873,000
Market Cap
150.21M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novartis AG | 75,883 |
DMAC News
- 4 weeks ago - DiaMedica Therapeutics Inc. (DMAC) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 5 weeks ago - DiaMedica Therapeutics Provides a Business Update and Announces Full Year 2024 Financial Results - Business Wire
- 5 weeks ago - DiaMedica Therapeutics to Report Fourth Quarter 2024 Financial Results and Provide a Business Update March 18, 2025 - Business Wire
- 2 months ago - DiaMedica Therapeutics Appoints Daniel J. O'Connor to the Board of Directors - Business Wire
- 2 months ago - DiaMedica Therapeutics Announces Publication of DM199's Mechanism of Action for the Treatment of Acute Ischemic Stroke (AIS) in the Journal Stroke - Business Wire
- 2 months ago - DiaMedica Therapeutics to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference - Business Wire
- 4 months ago - DiaMedica Therapeutics Announces Formation of Scientific Advisor Board to Support the Development of DM199 for the Treatment of Preeclampsia - Business Wire
- 5 months ago - DiaMedica Therapeutics Inc. (DMAC) Q3 2024 Earnings Call Transcript - Seeking Alpha